annual CFI:
$1.95B-$2.26B(-53.66%)Summary
- As of today (May 20, 2025), MRNA annual cash flow from investing activities is $1.95 billion, with the most recent change of -$2.26 billion (-53.66%) on December 31, 2024.
- During the last 3 years, MRNA annual CFI has risen by +$10.47 billion (+122.87%).
- MRNA annual CFI is now -53.66% below its all-time high of $4.21 billion, reached on December 31, 2023.
Performance
MRNA Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
$730.00M+$1.27B(+235.44%)Summary
- As of today (May 20, 2025), MRNA quarterly cash flow from investing activities is $730.00 million, with the most recent change of +$1.27 billion (+235.44%) on March 31, 2025.
- Over the past year, MRNA quarterly CFI has increased by +$612.00 million (+518.64%).
- MRNA quarterly CFI is now -63.70% below its all-time high of $2.01 billion, reached on March 31, 2023.
Performance
MRNA quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
$2.56B+$612.00M(+31.40%)Summary
- As of today (May 20, 2025), MRNA TTM cash flow from investing activities is $2.56 billion, with the most recent change of +$612.00 million (+31.40%) on March 31, 2025.
- Over the past year, MRNA TTM CFI has increased by +$248.00 million (+10.72%).
- MRNA TTM CFI is now -39.11% below its all-time high of $4.21 billion, reached on December 31, 2023.
Performance
MRNA TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
MRNA Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -53.7% | +518.6% | +10.7% |
| 3 y3 years | +122.9% | +118.6% | +120.9% |
| 5 y5 years | +10000.0% | +331.0% | +902.2% |
MRNA Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -53.7% | +122.9% | -63.7% | +118.6% | -39.1% | +120.9% |
| 5 y | 5-year | -53.7% | +122.9% | -63.7% | +118.6% | -39.1% | +120.9% |
| alltime | all time | -53.7% | +122.9% | -63.7% | +118.6% | -39.1% | +120.9% |
MRNA Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $730.00M(-235.4%) | $2.56B(+31.4%) |
| Dec 2024 | $1.95B(-53.7%) | -$539.00M(-174.8%) | $1.95B(-0.1%) |
| Sep 2024 | - | $721.00M(-56.3%) | $1.95B(-3.4%) |
| Jun 2024 | - | $1.65B(+1297.5%) | $2.02B(-12.8%) |
| Mar 2024 | - | $118.00M(-121.9%) | $2.31B(-45.0%) |
| Dec 2023 | $4.21B(-181.3%) | -$538.00M(-168.2%) | $4.21B(+13.8%) |
| Sep 2023 | - | $789.00M(-59.4%) | $3.70B(-4.0%) |
| Jun 2023 | - | $1.94B(-3.3%) | $3.85B(+409.5%) |
| Mar 2023 | - | $2.01B(-291.9%) | $756.00M(-114.6%) |
| Dec 2022 | -$5.18B(-39.3%) | -$1.05B(-210.9%) | -$5.18B(-1.7%) |
| Sep 2022 | - | $945.00M(-182.0%) | -$5.27B(-44.8%) |
| Jun 2022 | - | -$1.15B(-70.6%) | -$9.54B(-22.2%) |
| Mar 2022 | - | -$3.92B(+244.6%) | -$12.26B(+43.9%) |
| Dec 2021 | -$8.52B(+409.7%) | -$1.14B(-65.8%) | -$8.52B(+12.5%) |
| Sep 2021 | - | -$3.33B(-14.2%) | -$7.58B(+39.6%) |
| Jun 2021 | - | -$3.88B(+2054.4%) | -$5.43B(+253.3%) |
| Mar 2021 | - | -$180.00M(-5.3%) | -$1.54B(-8.1%) |
| Dec 2020 | -$1.67B(>+9900.0%) | -$190.00M(-83.9%) | -$1.67B(+23.7%) |
| Sep 2020 | - | -$1.18B(-9169.2%) | -$1.35B(+2177.9%) |
| Jun 2020 | - | $13.00M(-104.1%) | -$59.34M(-81.4%) |
| Mar 2020 | - | -$316.00M(-342.5%) | -$319.24M(+2028.3%) |
| Dec 2019 | -$15.00M(-96.0%) | $130.29M(+14.9%) | -$15.00M(-89.2%) |
| Sep 2019 | - | $113.37M(-145.9%) | -$139.12M(+2.0%) |
| Jun 2019 | - | -$246.90M(+1999.7%) | -$136.41M(-238.0%) |
| Mar 2019 | - | -$11.76M(-290.5%) | $98.85M(-126.5%) |
| Dec 2018 | -$373.09M(-189.4%) | $6.17M(-94.7%) | -$373.09M(-1.6%) |
| Sep 2018 | - | $116.08M(-1096.8%) | -$379.27M(-23.4%) |
| Jun 2018 | - | -$11.64M(-97.6%) | -$495.42M(+2.3%) |
| Mar 2018 | - | -$483.70M(<-9900.0%) | -$484.08M(>+9900.0%) |
| Dec 2017 | $417.36M(-164.3%) | $0.00(-100.0%) | -$375.00K(+1.6%) |
| Sep 2017 | - | -$75.00K(-75.0%) | -$369.10K(+25.5%) |
| Jun 2017 | - | -$300.00K(-5184.7%) | -$294.10K(-5084.7%) |
| Dec 2016 | -$648.61M(>+9900.0%) | - | - |
| Dec 2016 | - | $5900.00(>+9900.0%) | $5900.00(>+9900.0%) |
| Sep 2016 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2016 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2015 | -$45.00K(<-9900.0%) | - | - |
| Dec 2014 | $0.00(-100.0%) | - | - |
| Dec 2013 | $410.00K(-61.4%) | $0.00(0.0%) | $410.00K(-47.6%) |
| Sep 2013 | - | $0.00(-100.0%) | $782.00K(-42.2%) |
| Jun 2013 | - | $30.00K(-92.1%) | $1.35M(-4.5%) |
| Mar 2013 | - | $380.00K(+2.2%) | $1.42M(+33.3%) |
| Dec 2012 | $1.06M(>+9900.0%) | $372.00K(-34.7%) | $1.06M(+27.5%) |
| Sep 2012 | - | $570.00K(+506.4%) | $833.00K(+216.7%) |
| Jun 2012 | - | $94.00K(+261.5%) | $263.00K(+55.6%) |
| Mar 2012 | - | $26.00K(-81.8%) | $169.00K(+5533.3%) |
| Dec 2011 | $3000.00(-99.9%) | $143.00K(>+9900.0%) | $3000.00(-113.0%) |
| Sep 2011 | - | $0.00(0.0%) | -$23.00K(-100.5%) |
| Jun 2011 | - | $0.00(-100.0%) | $4.82M(+0.7%) |
| Mar 2011 | - | -$140.00K(-219.7%) | $4.78M(+3.1%) |
| Dec 2010 | $4.64M(+98.7%) | $117.00K(-97.6%) | $4.64M(-0.8%) |
| Sep 2010 | - | $4.84M(<-9900.0%) | $4.68M(+8728.3%) |
| Jun 2010 | - | -$33.00K(-88.4%) | $53.00K(-95.0%) |
| Mar 2010 | - | -$284.00K(-282.1%) | $1.06M(-54.6%) |
| Dec 2009 | $2.33M(-80.7%) | $156.00K(-27.1%) | $2.33M(+12.0%) |
| Sep 2009 | - | $214.00K(-78.0%) | $2.08M(-37.9%) |
| Jun 2009 | - | $974.00K(-1.7%) | $3.35M(-56.1%) |
| Mar 2009 | - | $991.00K(-1143.2%) | $7.65M(-36.8%) |
| Dec 2008 | $12.10M | -$95.00K(-106.4%) | $12.10M(-17.6%) |
| Sep 2008 | - | $1.48M(-71.8%) | $14.69M(+12.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2008 | - | $5.27M(-3.3%) | $13.01M(-37.2%) |
| Mar 2008 | - | $5.45M(+118.7%) | $20.72M(+343.1%) |
| Dec 2007 | $4.67M(+806.0%) | $2.49M(-1370.4%) | $4.67M(-60.6%) |
| Sep 2007 | - | -$196.00K(-101.5%) | $11.87M(+6.0%) |
| Jun 2007 | - | $12.98M(-222.5%) | $11.20M(-1754.5%) |
| Mar 2007 | - | -$10.60M(-209.4%) | -$677.00K(-231.2%) |
| Dec 2006 | $516.00K(-79.0%) | $9.69M(-1217.3%) | $516.00K(-93.6%) |
| Sep 2006 | - | -$867.00K(-178.9%) | $8.08M(-364.1%) |
| Jun 2006 | - | $1.10M(-111.7%) | -$3.06M(-50.2%) |
| Mar 2006 | - | -$9.40M(-154.5%) | -$6.14M(-349.5%) |
| Dec 2005 | $2.46M(-107.3%) | $17.25M(-243.7%) | $2.46M(-105.0%) |
| Sep 2005 | - | -$12.01M(+504.7%) | -$49.18M(+44.7%) |
| Jun 2005 | - | -$1.99M(+149.8%) | -$33.98M(-0.1%) |
| Mar 2005 | - | -$795.00K(-97.7%) | -$34.00M(+1.3%) |
| Dec 2004 | -$33.55M(-1063.6%) | -$34.39M(-1176.4%) | -$33.55M(<-9900.0%) |
| Sep 2004 | - | $3.19M(-258.8%) | $145.00K(-126.2%) |
| Jun 2004 | - | -$2.01M(+483.2%) | -$553.00K(-114.2%) |
| Mar 2004 | - | -$345.00K(-50.2%) | $3.89M(+11.8%) |
| Dec 2003 | $3.48M(-191.2%) | -$693.00K(-127.8%) | $3.48M(+2.5%) |
| Sep 2003 | - | $2.50M(+2.6%) | $3.40M(-375.1%) |
| Jun 2003 | - | $2.43M(-422.3%) | -$1.24M(-72.1%) |
| Mar 2003 | - | -$755.00K(-3.0%) | -$4.43M(+15.9%) |
| Dec 2002 | -$3.82M(+2571.3%) | -$778.00K(-63.6%) | -$3.82M(+24.6%) |
| Sep 2002 | - | -$2.13M(+180.6%) | -$3.06M(+211.2%) |
| Jun 2002 | - | -$761.00K(+421.2%) | -$985.00K(+313.9%) |
| Mar 2002 | - | -$146.00K(+534.8%) | -$238.00K(+66.4%) |
| Dec 2001 | -$143.00K(-104.2%) | -$23.00K(-58.2%) | -$143.00K(-17.8%) |
| Sep 2001 | - | -$55.00K(+292.9%) | -$174.00K(+10.8%) |
| Jun 2001 | - | -$14.00K(-72.5%) | -$157.00K(-40.1%) |
| Mar 2001 | - | -$51.00K(-5.6%) | -$262.00K(-107.7%) |
| Dec 2000 | $3.42M(-148.9%) | -$54.00K(+42.1%) | $3.42M(-298.5%) |
| Sep 2000 | - | -$38.00K(-68.1%) | -$1.72M(-38.1%) |
| Jun 2000 | - | -$119.00K(-103.3%) | -$2.79M(-9.2%) |
| Mar 2000 | - | $3.63M(-169.9%) | -$3.07M(-56.2%) |
| Dec 1999 | -$7.00M(+1066.7%) | -$5.20M(+372.7%) | -$7.00M(+268.4%) |
| Sep 1999 | - | -$1.10M(+175.0%) | -$1.90M(+90.0%) |
| Jun 1999 | - | -$400.00K(+33.3%) | -$1.00M(-145.5%) |
| Mar 1999 | - | -$300.00K(+200.0%) | $2.20M(-466.7%) |
| Dec 1998 | -$600.00K(-109.4%) | -$100.00K(-50.0%) | -$600.00K(0.0%) |
| Sep 1998 | - | -$200.00K(-107.1%) | -$600.00K(-140.0%) |
| Jun 1998 | - | $2.80M(-190.3%) | $1.50M(-11.8%) |
| Mar 1998 | - | -$3.10M(+3000.0%) | $1.70M(-73.4%) |
| Dec 1997 | $6.40M(-288.2%) | -$100.00K(-105.3%) | $6.40M(-1.5%) |
| Sep 1997 | - | $1.90M(-36.7%) | $6.50M(+160.0%) |
| Jun 1997 | - | $3.00M(+87.5%) | $2.50M(-1350.0%) |
| Mar 1997 | - | $1.60M(-176.2%) | -$200.00K(-88.9%) |
| Dec 1996 | -$3.40M(-1800.0%) | - | - |
| Sep 1996 | - | -$2.10M(-800.0%) | -$1.80M(-1000.0%) |
| Jun 1996 | $200.00K(0.0%) | $300.00K(-250.0%) | $200.00K(-85.7%) |
| Mar 1996 | - | -$200.00K(-200.0%) | $1.40M(-12.5%) |
| Dec 1995 | - | $200.00K(-300.0%) | $1.60M(-366.7%) |
| Sep 1995 | - | -$100.00K(-106.7%) | -$600.00K(-400.0%) |
| Jun 1995 | $200.00K(-110.0%) | $1.50M(>+9900.0%) | $200.00K(-115.4%) |
| Mar 1995 | - | $0.00(-100.0%) | -$1.30M(0.0%) |
| Dec 1994 | - | -$2.00M(-385.7%) | -$1.30M(+8.3%) |
| Sep 1994 | - | $700.00K(>+9900.0%) | -$1.20M(-40.0%) |
| Jun 1994 | -$2.00M | $0.00(0.0%) | -$2.00M(0.0%) |
| Mar 1994 | - | $0.00(-100.0%) | -$2.00M(0.0%) |
| Dec 1993 | - | -$1.90M(+1800.0%) | -$2.00M(+1900.0%) |
| Sep 1993 | - | -$100.00K | -$100.00K |
FAQ
- What is Moderna annual cash flow from investing activities?
- What is the all time high annual CFI for Moderna?
- What is Moderna annual CFI year-on-year change?
- What is Moderna quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Moderna?
- What is Moderna quarterly CFI year-on-year change?
- What is Moderna TTM cash flow from investing activities?
- What is the all time high TTM CFI for Moderna?
- What is Moderna TTM CFI year-on-year change?
What is Moderna annual cash flow from investing activities?
The current annual CFI of MRNA is $1.95B
What is the all time high annual CFI for Moderna?
Moderna all-time high annual cash flow from investing activities is $4.21B
What is Moderna annual CFI year-on-year change?
Over the past year, MRNA annual cash flow from investing activities has changed by -$2.26B (-53.66%)
What is Moderna quarterly cash flow from investing activities?
The current quarterly CFI of MRNA is $730.00M
What is the all time high quarterly CFI for Moderna?
Moderna all-time high quarterly cash flow from investing activities is $2.01B
What is Moderna quarterly CFI year-on-year change?
Over the past year, MRNA quarterly cash flow from investing activities has changed by +$612.00M (+518.64%)
What is Moderna TTM cash flow from investing activities?
The current TTM CFI of MRNA is $2.56B
What is the all time high TTM CFI for Moderna?
Moderna all-time high TTM cash flow from investing activities is $4.21B
What is Moderna TTM CFI year-on-year change?
Over the past year, MRNA TTM cash flow from investing activities has changed by +$248.00M (+10.72%)